You should not act or refrain from acting on the basis of any content included in this article without seeking medical, legal or other professional advice
Mounjaro side effects Tirzepatide has a well-documented safety profile thanks to years of post-market surveillance and extensive clinical trial data
This ability generally makes GLP-1/GIP options cause more blood sugar control and weight loss compared to GLP-1 options
The Endocrine Society's clinical practice guideline on GH deficiency states: "GH therapy is contraindicated in patients with active malignancy" [10]
However, the total weight lost on GLP-1 medications far exceeds phentermine by the end of treatment
Masson W, Lobo M, Nogueira JP, Rodriguez-Granillo AM, Barbagelata LE, Siniawski D